Cambium Medical Technologies Business Model

Dry Eye
Cambium remains focused on completing development, obtaining regulatory approvals and commercializing directly and through strategic partners its Elate Ocular™ biologic eye drop for dry eye syndrome.
Other Therapeutic Applications
Cambium plans to pursue therapeutic applications of its Aurarix™ novel platelets in numerous additional medical fields—directly and through strategic partners.  As an example, ZYBT (Taiwan) is Cambium’s partner regarding the worldwide cell growth supplement market.  Additional markets of interest to Cambium for its Aurarix™ novel platelets are:
  • Orthopedics – e.g., platelet rich plasma to improve tissue repair, osteoarthritis, tennis elbow, spinal surgery
  • Wound healing – chronic skin ulcers
  • Sports medicine – acute and chronic tendon, ligament and muscle injuries
  • Dentistry – to increase bone density
  • ENT
  • Neurosurgery
  • Urology
  • Cosmetics
  • Dermatology
  • Cardiothoracic
  • Maxillofacial surgery